Cite

HARVARD Citation

    Cuccia, F. et al. (n.d.). PO-1388 1.5 T MR-guided SBRT for oligorecurrent prostate cancer: preliminary report of feasibility and PROMs. Radiotherapy and oncology. pp. S1138-S1139. [Online]. 
  
Back to record